This Cochrane review of the effects of periodontal treatment on glycaemic control in people with diabetes mellitus and periodontitis updates the 2015 version. The earlier conclusions have changed and there is now moderate‐certainty evidence that periodontal treatment using subgingival instrumentation improves glycaemic control in those with periodontitis and diabetes.
[read the full story...]Periodontal treatment and glycaemic control in diabetes
This review of the efficacy of scaling and root planning (SRP) and SRP + adjuvant treatments in improving glycaemic control in patients with type 2 diabetes mellitus and chronic periodontitis included 14 RCTs suggesting some benefit in the short term.
[read the full story...]Diabetic patients: does periodontal treatment improve glycaemic control?
91 diabetic patients were randomised to non-surgical scaling and root planing and amoxicillin or control. While periodontal status significantly improved at 3 months there was no no significant effects on
glycaemic control.
Periodontal disease and glycaemic control in diabetics
This review of the impact of periodontal treatment in diabetics in this latest in a long list of publications on this topic . This review only includes 7 trials and supports the effectiveness of periodontal therapy in glycemic control in type 2 diabetic patients and periodontitis. Other more detailed reviews are available.
[read the full story...]Periodontal disease and glycaemic control in diabetics
11 systematic reviews were included in this overview of review of periodontal disease and glycaemic control in diabetics. The primary studies that underlying these systematic reviews have important limitations. Therefore larger higher quality studies are needed.
[read the full story...]Low quality evidence that periodontal treatment improves glycaemic control in diabetics
This update of a 2010 Cochrane review found low quality evidence that periodontal treatment involving scaling and root planing does improve glycaemic control in people with diabetes, with a mean percentage reduction in HbA1c of 0.29% at 3-4 months, but there is insufficient evidence to demonstrate that this is maintained after 4 months.
[read the full story...]